Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores

被引：108
作者：
Lip, G. Y. H. [1 ,2 ]
Lane, D. A. [1 ,2 ]
机构：
[1] Univ Birmingham, Inst Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England
[2] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2016年 / 14卷 / 09期
关键词：
STROKE PREVENTION; WARFARIN; ANTICOAGULATION;
D O I：
10.1111/jth.13386
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1711 / 1714
页数：4
相关论文
共 20 条
[1]   A New Risk Scheme to Predict Warfarin-Associated Hemorrhage The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study [J].
Fang, Margaret C. ;
Go, Alan S. ;
Chang, Yuchiao ;
Borowsky, Leila H. ;
Pomernacki, Niela K. ;
Udaltsova, Natalia ;
Singer, Daniel E. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (04) :395-401
[2]   Low performance of bleeding risk models in the very elderly with atrial fibrillation using vitamin K antagonists [J].
Focks, J. Jaspers ;
van Vugt, S. P. G. ;
Albers-Akkers, M. T. H. ;
Lamfers, E. J. P. ;
Bloem-de Vries, L. M. ;
Verheugt, F. W. A. ;
Brouwer, M. A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (09) :1715-1724
[3]   Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation A Report From the Swedish Atrial Fibrillation Cohort Study [J].
Friberg, Leif ;
Rosenqvist, Marten ;
Lip, Gregory Y. H. .
CIRCULATION, 2012, 125 (19) :2298-+
[4]   The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study [J].
Hijazi, Ziad ;
Oldgren, Jonas ;
Lindback, Johan ;
Alexander, John H. ;
Connolly, Stuart J. ;
Eikelboom, John W. ;
Ezekowitz, Michael D. ;
Held, Claes ;
Hylek, Elaine M. ;
Lopes, Renato D. ;
Siegbahn, Agneta ;
Yusuf, Salim ;
Granger, Christopher B. ;
Wallentin, Lars .
LANCET, 2016, 387 (10035) :2302-2311
[5]   Biomarkers in atrial fibrillation: a clinical review [J].
Hijazi, Ziad ;
Oldgren, Jonas ;
Siegbahn, Agneta ;
Granger, Christopher B. ;
Wallentin, Lars .
EUROPEAN HEART JOURNAL, 2013, 34 (20) :1475-+
[6]   Evaluation of patients' attitudes towards stroke prevention and bleeding risk in atrial fibrillation [J].
LaHaye, Stephen ;
Regpala, Steffi ;
Lacombe, Shawn ;
Sharma, Mukul ;
Gibbens, Sabra ;
Ball, David ;
Francis, Kori .
THROMBOSIS AND HAEMOSTASIS, 2014, 111 (03) :465-473
[7]   Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation [J].
Lane, Deirdre A. ;
Lip, Gregory Y. H. .
THROMBOSIS AND HAEMOSTASIS, 2014, 111 (03) :381-383
[8]   Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation [J].
Lip, Gregory Y. H. ;
Lane, Deirdre ;
Van Walraven, Carl ;
Hart, Robert G. .
STROKE, 2006, 37 (09) :2294-2300
[9]   Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors [J].
Lip, Gregory Y. H. ;
Lane, Deirdre A. .
EUROPEAN HEART JOURNAL, 2015, 36 (46) :3265-3267
[10]   Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score [J].
Lip, Gregory Y. H. ;
Skjoth, Flemming ;
Nielsen, Peter B. ;
Larsen, Torben Bjerregaard .
THROMBOSIS AND HAEMOSTASIS, 2015, 114 (04) :826-834
12